Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype

被引:51
|
作者
Vinagre, Irene [1 ,2 ]
Luis Sanchez-Quesada, Jose [3 ]
Sanchez-Hernandez, Juan [4 ]
Santos, David [3 ,4 ]
Ordonez-Llanos, Jordi [3 ,5 ,6 ]
De Leiva, Alberto [1 ,7 ]
Perez, Antonio [1 ,4 ]
机构
[1] Hosp Santa Creu & Sant Pau, Endocrinol & Nutr Dept, Barcelona 08025, Spain
[2] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[3] IIB Sant Pau, Biomed Res Inst, Barcelona, Spain
[4] CIBER Diabet & Metab Dis CIBERDEM, Barcelona, Spain
[5] Hosp Santa Creu & Sant Pau, Dept Biochem, Barcelona 08025, Spain
[6] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain
[7] CIBERBBN, Barcelona, Spain
来源
关键词
Inflammatory biomarkers; C-reactive protein; Adiponectin; Monocyte chemotactic protein-1; Transforming growth factor-beta(1); Tumor growth factor beta(1); Type; 2; diabetes; LDL phenotype; Atherogenic dyslipidemia; C-REACTIVE PROTEIN; INSULIN-RESISTANCE ATHEROSCLEROSIS; NECROSIS-FACTOR-ALPHA; ACUTE-PHASE PROTEINS; TNF-ALPHA; HYPERTENSIVE PATIENTS; SERUM CONCENTRATIONS; METABOLIC SYNDROME; MESANGIAL CELLS; ELEVATED LEVELS;
D O I
10.1186/1475-2840-13-34
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Type 2 diabetes mellitus (T2D) is associated with higher cardiovascular risk partly related to an increase in inflammatory parameters. The aim of this study was to determine the association of inflammatory biomarkers with low-density lipoprotein (LDL) subfraction phenotype and glycemic control in subjects with T2D and poor glycemic control. Methods: A cross-sectional study was performed comparing 122 subjects with T2D (59 +/- 11 years old, body mass index 30.2 +/- 5.6 kg/m2) with 54 control subjects. Patients with T2D were classified according to their LDL subfraction phenotype and inflammatory biomarkers (C-reactive protein, Interleukin-6, Interleukin-8, Transforming growth factor beta(1), Monocyte chemotactic protein 1, Leptin, Adiponectin) were evaluated according to the degree of glycemic control, LDL phenotype and other clinical characteristics. Forty-two subjects with T2D were studied before and after 3 months of improving glycemic control by different strategies. Results: Patients with T2D had higher C-reactive protein (CRP) and monocyte chemotactic protein-1 (MCP1) levels and lower adiponectin concentration, compared to controls. T2D subjects with body mass index >= 30 kg/m2 had higher CRP levels (5.2 +/- 4.8 mg/l vs 3.7 +/- 4.3 mg/l; p < 0.05). The presence of LDL phenotype B was related to higher levels of transforming growth factor-beta(1) (TGF-beta(1)) (53.92 +/- 52.82 ng/l vs 31.35 +/- 33.74 ng/l; p < 0.05) and lower levels of adiponectin (3663 +/- 3044 ng/l vs 2723 +/- 1776 ng/l; p < 0.05). The reduction of HbA1c from 9.5 +/- 1.8% at baseline to 7.4 +/- 0.8% was associated with a significant reduction of TGF-beta(1) (41.86 +/- 32.84 ng/l vs 26.64 +/- 26.91 ng/l; p = 0.02). Conclusions: Subjects with T2D, especially those with LDL phenotype B and obesity, have higher levels of inflammatory biomarkers. Improvement of glycemic control reduces TGF-beta(1) levels, which may contribute partly to its renoprotective role.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Determinants of Glycemic Control and Quality of Life In Type 2 Diabetic Patients
    Souza, Rodrigo A. P.
    Correr, Cassyano J.
    Melchiors, Ana C.
    Sanches, Andreia C. C.
    Wiens, Astrid
    Pontarolo, Roberto
    LATIN AMERICAN JOURNAL OF PHARMACY, 2011, 30 (05): : 860 - 867
  • [32] Glycemic control in hemodialized type 2 diabetic patients: Interest of CGMS
    Riveline, J. P.
    Teynie, J.
    Belmouaz, S.
    Franc, S.
    Dardari, D.
    Bauwens, M.
    Caudwell, V.
    Ragot, S.
    Bridoux, F.
    Charpentier, G.
    Marechaud, R.
    Hadjadj, S.
    DIABETES & METABOLISM, 2009, 35 : A20 - A20
  • [33] DENOSUMAB IMPROVES GLYCEMIC CONTROL OF TYPE 2 DIABETIC PATIENTS WITH OSTEOPOROSIS
    Chews, C. K.
    Khosla, S.
    Rizza, R.
    Geske, J.
    Clarke, B.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S57 - S58
  • [34] Impact of Sleep on Glycemic Control in Type 2 Diabetic Patients in Prince Mansour Hospital, Taif, KSA
    Obaid, Zafar Hamzah
    Alzaydi, Mohammed Deifallah
    Safar, Mubarak Ali
    Almalki, Abdulrahman Ghurmullah S.
    Obaid, Dhafar Yahia A.
    Shalwala, Abdulrahman Rafat
    Dhafar, Sarah Obaid
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2018, 7 (03): : 108 - 115
  • [35] Association of Lung Function Indices with Inflammatory Marker (hsCRP) and Glycemic Control in Type 2 Diabetic Patients of Karachi
    Kanpurwala, Muhammad Adnan
    Qureshi, Masood A.
    Ayoob, Zeenat
    Shaikh, Zaman
    FASEB JOURNAL, 2016, 30
  • [36] The effect of glycemic control on salivary lipid peroxidation in type II diabetic patients
    Shirzaiy, Masoomeh
    Dalirsani, Zohreh
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (03) : 1991 - 1994
  • [37] EFFECT OF WAR ON GLYCEMIC CONTROL IN TYPE-II DIABETIC-PATIENTS
    ROGLIC, G
    METELKO, Z
    DIABETES CARE, 1993, 16 (05) : 806 - 808
  • [38] Effects of Glycemic Control by Administration of Sitagliptin in Type 2 Diabetic Patients With Insufficient Control
    Wago, Takehiko
    Tanaka, Shunichi
    DIABETES, 2013, 62 : A750 - A750
  • [39] Impact of Dietary Pattern on Glycemic Level Among Type 2 Diabetic Patients
    Habib, Farah
    Durrani, Anisa. M.
    CURRENT RESEARCH IN NUTRITION AND FOOD SCIENCE, 2018, 6 (01) : 120 - 126
  • [40] The Effect of High Dose Vitamin D Supplementation on Glycemic Control in Healthy Type 2 Diabetic Patients
    Ryu, Ohk Hyun
    Lee, Sunghwa
    Choi, Moon-Gi
    Yu, Jae Myung
    Kim, Doo-Man
    Ihm, Sung-Hee
    Yoo, Hyung Joon
    DIABETES, 2013, 62 : A292 - A292